Piloting FDA SHIELD's LOINC to In Vitro Diagnostic (LIVD) Specification in Five Medical Centers: Implications for Interoperability - researchr publication authors

researchr

You are not signed in
Sign in
Sign up

Greg Rehwoldt, Raja A. Cholan, Andrew K. Sills, I Khalil Appleton, Timothy Williams, Natalie M. Scott, Gregory Pappas. Piloting FDA SHIELD's LOINC to In Vitro Diagnostic (LIVD) Specification in Five Medical Centers: Implications for Interoperability. In AMIA 2021, American Medical Informatics Association Annual Symposium, San Diego, CA, USA, October 30, 2021 - November 3, 2021. AMIA, 2021. [doi]

This author has not been identified. Look up 'Greg Rehwoldt' in GoogleThis author has not been identified. Look up 'Raja A. Cholan' in GoogleThis author has not been identified. Look up 'Andrew K. Sills' in GoogleThis author has not been identified. Look up 'I Khalil Appleton' in GoogleThis author has not been identified. Look up 'Timothy Williams' in GoogleThis author has not been identified. Look up 'Natalie M. Scott' in GoogleThis author has not been identified. Look up 'Gregory Pappas' in Google

runs on WebDSL